DexCom Inc (DXCM)

114.06 +1.40 (+1.24%)
Close USD Disclaimer
115.00 +0.94 (+0.82%)

DexCom Inc Company Profile

Equity Type
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Contact Information
San Diego,92121 United States
858 200 0200
Top Executives
Kevin Ronald Sayer 64 2007 Executive Chairman, CEO & President
Eric J. Topol 70 2009 Independent Director
Mark G. Foletta 63 2014 Lead Independent Director
Bridgette P. Heller 63 2019 Independent Director
Steven R. Altman 63 2013 Independent Director
Kyle Malady 56 2020 Independent Director
Richard A. Collins 67 2017 Independent Director
Karen M. Dahut 60 2020 Independent Director
Rimma Driscoll 51 2023 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles